Skip to content

Personalizing Treatment for Patients With Asthma

Asthma is a chronic obstructive respiratory disease that affects more than 300 million people world-wide and more than 25 million children and adults in the United States. There is an urgent need to improve the care of the estimated 5% to 10% of these patients who have severe asthma, which accounts for an outsized proportion of the disease’s morbidity, mortality, and healthcare costs. Approximately 50% of patients with asthma continue to have “not well-controlled” or “poorly controlled” asthma despite using recommended step-care treatment. Poorly controlled asthma is a significant contributor to poor quality of life, and inadequate response to therapy indicates the need to review and modify treatment. Asthma education and training can be effectively delivered by a range of health clinicians, including pharmacists. Continuing education of clinicians serving on the front lines is vital to quality asthma management.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe the pathophysiologic features of asthma, including new insights into disease phenotypes and therapeutic targets for biologic medications.
  • Compare and contrast key recommendations from the National Asthma Education and Prevention Program Expert Panel Report 3 (NAEPP EPR-3) and The Global Initiative for Asthma (GINA) Program.
  • Explain a stepwise approach to recommend effective pharmacotherapy based on asthma severity and subtype.
  • List potential advantages and possible shortcomings of available inhalation delivery systems to individualize asthma therapy.
  • Recognize the proper use of various inhalation devices to support patient self-management education.


Timothy R. Hudd, BS, PharmD, R.Ph., AE-C
Dr. Hudd is an Associate Professor of Pharmacy Practice at MCPHS University and has served on the faculty for the past 16 years. He serves as a clinical ambulatory care faculty preceptor at Merrimack Family Medicine in Tewksbury, MA and delivers lectures on pulmonary related topics for several graduate and post-graduate programs. He has published multiple articles on pulmonary related topics and recently served as a section editor and chapter author for the textbook Applied Therapeutics: The Clinical Use of Drugs, 11th edition. He is a past recipient of the “Pharmacy Practice Teacher of the Year”, “Faculty Preceptor of the Year, and is a Past President of the Massachusetts Pharmacists Association (MPhA). Dr. Hudd is nationally certified as an Asthma Educator (AE-C) and is currently serving as Chair for the National Asthma Educator Certification Board (NAECB). He works with several statewide asthma advocacy groups including the Massachusetts Department of Public Health (MA DPH) and the Massachusetts Asthma Prevention and Control Program (APCP).


ACPE logo

Release Date: June 26, 2019
Expiration Date: March 14, 2021
Contact Hours: 1.5
Universal Activity Number: 0026-0000-19-020-H01-P
ACPE Topic Designator: Disease State Management/Drug Therapy

Registration Fee: Free to MCPHS Alumni and full-time employees; $12.00 for all other professionals.